MARKET DEFINITION

A contrast agent, often known as contrast media, is a material used in medical imaging to improve the contrast of internal structures or fluids. Contrast agents, unlike radiopharmaceuticals, absorb or modify external electromagnetic or ultrasonic waves, whereas radiopharmaceuticals generate radiation. These medications can be given to the patient orally, rectally, or intravenously. Contrast media/agent modifies the way medical imaging equipment interacts with the body for a brief duration, allowing certain portions of the body to be distinguished from surrounding tissue. It aids in the visibility of blood vessels, specific tissues, and organs. Contrast media/contrast agents improve internal body images obtained during an ultrasound, X-ray, MRI, and CT studies.

MARKET DYNAMICS

As the global frequency of chronic diseases has increased, so has the demand for diagnostic imaging methods and, as a result, contrast media. The growing demand for imaging treatments has necessitated substantial R&D by contrast media makers in order to offer fresh products and obtain approval for new indications. However, severe side effects and allergic reactions may hinder the market growth. Their adverse effects range from mild to severe, with severe reactions and severe allergic reactions being the most harmful. Furthermore, the increased contrast of fluids and biological structures during medical imaging may provide enormous potential opportunities for the X-Ray contrast media industry.

REPORT SCOPE

The report titled “Global X-Ray Contrast Agents Market – Size, Share, Growth, Opportunities, and Competitive Analysis, 2022 – 2028” offers strategic visions into the global X-Ray Contrast Agents market along with the market size (Value in “US$ Mn”) for the historical period 2017 to 2021 and estimates for the forecast period 2022 to 2028. The RI report is an in-depth study of the global X-Ray Contrast Agents market with a strong focus on key market trends, vital player strategies, and market forecasts. The study also covers key market dynamics, including drivers, restraints, opportunities, challenges, and existing and upcoming pathways that help CXOs make critical business decisions effectively. The global X-Ray Contrast Agents Market is predicted to grow at a significant CAGR over the forecast period from 2022 to 2028.

GEOGRAPHICAL OVERVIEW

The research report includes a detailed overview of the industry comprising quantitative and qualitative information. It gives a broad overview of the worldwide market forecasts for major segments. It also includes market size and forecast projections for five key regions: North America, Europe, Asia-Pacific (APAC), South America, and the Middle East & Africa (MEA), for the years 2017 to 2028. The market is further divided by categories and countries within each province. The research scrutinizes and forecasts over 20 nations worldwide, as well as the present trend and possibilities in these regions.

MARKET SEGMENTATION

The Global X-Ray Contrast Agents Market is segmented based on media/agent type, mode of administration, indication, end user, and region. Based on media/agent type, the market has been segmented into Iodinated Contrast Media, Gadolinium-based Contrast Media, Microbubble Contrast Media, Barium-based Contrast Media, and Others, whereas based on the mode of administration, the market comprises Oral, Rectal, Intravenous/Intraarterial, and Others. Based on indication, the market has been segmented into Cardiovascular Disorders, Cancer, Gastrointestinal Disorders, Musculoskeletal Disorders, Neurological Disorders, Nephrological Disorders, and Others, whereas, the end user segmentation includes Hospitals, Clinics, Ambulatory Surgery Centers, and Others.

COMPETITION LANDSCAPE

The RI research report discusses noteworthy developments in the industry as well as organic and inorganic growth strategies being adopted by the X-Ray Contrast Agents market players. The report covers industry activities, including new product launches, mergers & acquisitions, business partnerships, and various expansion initiatives being undertaken by the active players in the market. These developments pave the path for various market participants to strengthen their positioning as well as expand their consumer base. The positive market outlook for the global X-Ray Contrast Agents market is anticipated to present lucrative growth opportunities to the market players. The report also offers detailed profiles of major players in the global X-Ray Contrast Agents market, emphasizing the strategic initiatives, financial information, SWOT analysis, and key development in the X-Ray Contrast Agents industry in the past three years.

Key players in the Global X-Ray Contrast Agents Market have adopted various organic as well as inorganic growth strategies to strengthen their market positioning. Prominent players in the market include:

• GE Healthcare
• Bracco Imaging SPA
• Bayer AG
• Guerbet
• Lantheus Medical Imaging, Inc.
• Unijules Life Sciences
• JB Pharma
• SANOCHEMIA Pharmazeutika GmbH
• Jodas Expoim
• Nano Therapeutics Pvt. Ltd.
• Kiran X-ray
• iMax Diagnostic Imaging Limited
• Livealth Biopharma Pvt. Ltd.
• Trivitron Healthcare Pvt. Ltd.

COVID-19 IMPACT ANALYSIS ON GLOBAL X-RAY CONTRAST AGENTS MARKET

The COVID-19 pandemic is still a very personal, individual experience that is also a once-in-a-lifetime worldwide phenomenon with far-reaching consequences. The epidemic has wreaked havoc on people's lives in all nations and communities and also had a negative impact on global economic development in 2020, unlike anything seen in almost a century. The pandemic severely impacted key economies such as India, Brazil, the U.S., France, Russia, the UK, Italy, Turkey, and Argentina. According to estimates, the virus slowed global economic growth by -3.4 percent to -7.6 percent in 2020, with a rebound of 4.2 percent to 5.6 percent expected in 2021. In 2020, global commerce was expected to decline by 5.3 percent, but it is expected to rise by 8.0 percent in 2021.

In contrast to the global economic downturn in the first half of 2020, the economy began to showcase symptoms of a two-track recovery post the second quarter of 2020, with a fledgling rebound in developed nations, however, slower growth in emerging economies. The outbreak of the Covid-19 pandemic has not only resulted in halted production activity but has also disrupted the global supply chain. The research goes on to evaluate the current and future implications of the COVID-19 pandemic both on the target as well as broader market, thereby, providing accurate and trustworthy forecasts.

RESEARCH PROGRAM DESIGN

KEY QUESTIONS ANSWERED

1. What is the current size of the global X-Ray Contrast Agents market?
2. What will be the growth rate of the market over the forecast period?
3. Who are the key manufacturers/vendors in the X-Ray Contrast Agents market space?
4. What are the major market opportunities and market risks faced by the market?
5. What is the impact of COVID-19 on the market?
6. What are the revenue, sales, and price analysis of the top manufacturers in this market?
7. What are the key outcomes of Porter's five forces model?
8. Who are the distributors, traders, and vendors in the industry?

REASONS FOR BUYING THIS REPORT:

• The report offers comprehensive data on the X-Ray Contrast Agents market elaborating on the current state and future growth prospects both globally and regionally
• It offers a six-year market forecast trend evaluating the impact of drivers and restraints and supporting factors for growth
• The report offers deep-dive insights into each market segment and critical factors responsible for its growth
• The report presents precise picture of the dynamic competitive landscape which helps our client advance their market position
• The comprehensive analysis of the market along with the inclusion of analyst recommendations ensures that our clients make informed business decisions
• Cross-segment country-level analysis included in the report which provides granular analysis of more than 20+ countries covered in the report scope
• The study includes detailed profiles of major manufacturers to help our readers gain holistic overview of the market competitors and consequently align their business strategies

Chapter 1. Executive Summary
1.1. Market Outlook
1.2. Market Segment Outlook
1.3. Geography Outlook
1.4. Absolute $ Opportunity
 
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Scope, Definition, and Assumptions
2.3. Data Sources
2.3.1. Secondary Sources
2.3.1.1. Preliminary Data Mining
2.3.2. Primary Sources
2.3.2.1. Statistical Model
2.3.2.2. Data Triangulation
2.3.2.3. Research Objective
 
Chapter 3. Market Outlook
3.1. Introduction
3.2. Key Trends
3.2.1. Media/Agent Type Trends
3.2.2. Mode of Administration Trends
3.2.3. Indication Trends
3.2.4. End User Trends
3.3. Market Dynamics
3.3.1. Market Drivers
3.3.1.1. Impact Analysis of Market Drivers
3.3.2. Market Restraints
3.3.2.1. Impact Analysis of Market Restraints
3.3.3. Market Opportunities
3.3.3.1. Impact Analysis of Market Opportunities
3.3.4. Market Challenges
3.3.4.1. Impact Analysis of Market Challenges
3.4. Porter’s Five Forces’ Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of New Entrant
3.4.4. Threat of Substitutes
3.4.5. Competitive Rivalry
3.5. Value Chain Analysis: Global X-Ray Contrast Agents Market
3.6. COVID-19 Impact Assessment in X-Ray Contrast Agents Market
3.6.1. Impact Assessment on Global X-Ray Contrast Agents Market
3.6.2. Market Trends and Opportunities in the Covid-19 Landscape
 
Chapter 4. Global X-Ray Contrast Agents Market Overview, By Media/Agent Type, 2017 - 2028 (USD Million)
4.1. Global X-Ray Contrast Agents Market Share, By Media/Agent Type, 2017 - 2028 (USD Million)
4.1.1. Iodinated Contrast Media
4.1.2. Gadolinium-based Contrast Media
4.1.3. Microbubble Contrast Media
4.1.4. Barium-based Contrast Media
4.1.5. Others
 
Chapter 5. Global X-Ray Contrast Agents Market Overview, By Mode of Administration, 2017 - 2028 (USD Million)
5.1. Global X-Ray Contrast Agents Market Share, By Mode of Administration, 2017 - 2028 (USD Million)
5.1.1. Oral
5.1.2. Rectal
5.1.3. Intravenous/Intraarterial
5.1.4. Others
 
Chapter 6. Global X-Ray Contrast Agents Market Overview, By Indication, 2017 - 2028 (USD Million)
6.1. Global X-Ray Contrast Agents Market Share, By Indication, 2017 - 2028 (USD Million)
6.1.1. Cardiovascular Disorders
6.1.2. Cancer
6.1.3. Gastrointestinal Disorders
6.1.4. Musculoskeletal Disorders
6.1.5. Neurological Disorders
6.1.6. Nephrological Disorders
6.1.7. Others
 
Chapter 7. Global X-Ray Contrast Agents Market Overview, By End User, 2017 - 2028 (USD Million)
7.1. Global X-Ray Contrast Agents Market Share, By End User, 2017 - 2028 (USD Million)
7.1.1. Hospitals
7.1.2. Clinics
7.1.3. Ambulatory Surgery Centers
7.1.4. Others
 
Chapter 8. Global X-Ray Contrast Agents Market Overview, By Geography, 2017 - 2028 (USD Million)
8.1. Global X-Ray Contrast Agents Market Share, By Geography, 2017 - 2028 (USD Million)
8.1.1. Market Size and Projections, by Countries, 2017 - 2028 (USD Million)
8.1.2. Market Share and CAGR Comparison, by Countries, 2021 (%)
 
Chapter 9. North America X-Ray Contrast Agents Market Overview, By Countries, 2017 - 2028 (USD Million)
9.1. North America X-Ray Contrast Agents Market Overview, 2017 - 2028 (USD Million)
9.1.1. Market size and projections, 2017 - 2028 (USD Million)
9.1.2. North America X-Ray Contrast Agents Market Overview, By Media/Agent Type, 2017 - 2028 (USD Million)
9.1.3. North America X-Ray Contrast Agents Market Overview, By Mode of Administration, 2017 - 2028 (USD Million)
9.1.4. North America X-Ray Contrast Agents Market Overview, By Indication, 2017 - 2028 (USD Million)
9.1.5. North America X-Ray Contrast Agents Market Overview, By End User, 2017 - 2028 (USD Million)
9.2. North America X-Ray Contrast Agents Market Overview, By Countries, 2017 - 2028 (USD Million)
9.2.1. U.S. X-Ray Contrast Agents Market Overview, 2017 - 2028 (USD Million)
9.2.1.1. U.S. X-Ray Contrast Agents Market Overview, By Media/Agent Type, 2017 - 2028 (USD Million)
9.2.1.2. U.S. X-Ray Contrast Agents Market Overview, By Mode of Administration, 2017 - 2028 (USD Million)
9.2.1.3. U.S. X-Ray Contrast Agents Market Overview, By Indication, 2017 - 2028 (USD Million)
9.2.1.4. U.S. X-Ray Contrast Agents Market Overview, By End User, 2017 - 2028 (USD Million)
9.2.2. Canada X-Ray Contrast Agents Market Overview, 2017 - 2028 (USD Million)
9.2.2.1. Canada X-Ray Contrast Agents Market Overview, By Media/Agent Type, 2017 - 2028 (USD Million)
9.2.2.2. Canada X-Ray Contrast Agents Market Overview, By Mode of Administration, 2017 - 2028 (USD Million)
9.2.2.3. Canada X-Ray Contrast Agents Market Overview, By Indication, 2017 - 2028 (USD Million)
9.2.2.4. Canada X-Ray Contrast Agents Market Overview, By End User, 2017 - 2028 (USD Million)
9.2.3. Mexico X-Ray Contrast Agents Market Overview, 2017 - 2028 (USD Million)
9.2.3.1. Mexico X-Ray Contrast Agents Market Overview, By Media/Agent Type, 2017 - 2028 (USD Million)
9.2.3.2. Mexico X-Ray Contrast Agents Market Overview, By Mode of Administration, 2017 - 2028 (USD Million)
9.2.3.3. Mexico X-Ray Contrast Agents Market Overview, By Indication, 2017 - 2028 (USD Million)
9.2.3.4. Mexico X-Ray Contrast Agents Market Overview, By End User, 2017 - 2028 (USD Million)
 
Chapter 10. Europe X-Ray Contrast Agents Market Overview, By Countries, 2017 - 2028 (USD Million)
10.1. Europe X-Ray Contrast Agents Market Overview, 2017 - 2028 (USD Million)
10.1.1. Market size and projections, 2017 - 2028 (USD Million)
10.1.2. Europe X-Ray Contrast Agents Market Overview, By Media/Agent Type, 2017 - 2028 (USD Million)
10.1.3. Europe X-Ray Contrast Agents Market Overview, By Mode of Administration, 2017 - 2028 (USD Million)
10.1.4. Europe X-Ray Contrast Agents Market Overview, By Indication, 2017 - 2028 (USD Million)
10.1.5. Europe X-Ray Contrast Agents Market Overview, By End User, 2017 - 2028 (USD Million)
10.2. Europe X-Ray Contrast Agents Market Overview, By Countries, 2017 - 2028 (USD Million)
10.2.1. Germany X-Ray Contrast Agents Market Overview, 2017 - 2028 (USD Million)
10.2.1.1. Germany X-Ray Contrast Agents Market Overview, By Media/Agent Type, 2017 - 2028 (USD Million)
10.2.1.2. Germany X-Ray Contrast Agents Market Overview, By Mode of Administration, 2017 - 2028 (USD Million)
10.2.1.3. Germany X-Ray Contrast Agents Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.1.4. Germany X-Ray Contrast Agents Market Overview, By End User, 2017 - 2028 (USD Million)
10.2.2. France X-Ray Contrast Agents Market Overview, 2017 - 2028 (USD Million)
10.2.2.1. France X-Ray Contrast Agents Market Overview, By Media/Agent Type, 2017 - 2028 (USD Million)
10.2.2.2. France X-Ray Contrast Agents Market Overview, By Mode of Administration, 2017 - 2028 (USD Million)
10.2.2.3. France X-Ray Contrast Agents Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.2.4. France X-Ray Contrast Agents Market Overview, By End User, 2017 - 2028 (USD Million)
10.2.3. UK X-Ray Contrast Agents Market Overview, 2017 - 2028 (USD Million)
10.2.3.1. UK X-Ray Contrast Agents Market Overview, By Media/Agent Type, 2017 - 2028 (USD Million)
10.2.3.2. UK X-Ray Contrast Agents Market Overview, By Mode of Administration, 2017 - 2028 (USD Million)
10.2.3.3. UK X-Ray Contrast Agents Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.3.4. UK X-Ray Contrast Agents Market Overview, By End User, 2017 - 2028 (USD Million)
10.2.4. Italy X-Ray Contrast Agents Market Overview, 2017 - 2028 (USD Million)
10.2.4.1. Italy X-Ray Contrast Agents Market Overview, By Media/Agent Type, 2017 - 2028 (USD Million)
10.2.4.2. Italy X-Ray Contrast Agents Market Overview, By Mode of Administration, 2017 - 2028 (USD Million)
10.2.4.3. Italy X-Ray Contrast Agents Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.4.4. Italy X-Ray Contrast Agents Market Overview, By End User, 2017 - 2028 (USD Million)
10.2.5. Spain X-Ray Contrast Agents Market Overview, 2017 - 2028 (USD Million)
10.2.5.1. Spain X-Ray Contrast Agents Market Overview, By Media/Agent Type, 2017 - 2028 (USD Million)
10.2.5.2. Spain X-Ray Contrast Agents Market Overview, By Mode of Administration, 2017 - 2028 (USD Million)
10.2.5.3. Spain X-Ray Contrast Agents Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.5.4. Spain X-Ray Contrast Agents Market Overview, By End User, 2017 - 2028 (USD Million)
10.2.6. NORDIC X-Ray Contrast Agents Market Overview, 2017 - 2028 (USD Million)
10.2.6.1. NORDIC X-Ray Contrast Agents Market Overview, By Media/Agent Type, 2017 - 2028 (USD Million)
10.2.6.2. NORDIC X-Ray Contrast Agents Market Overview, By Mode of Administration, 2017 - 2028 (USD Million)
10.2.6.3. NORDIC X-Ray Contrast Agents Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.6.4. NORDIC X-Ray Contrast Agents Market Overview, By End User, 2017 - 2028 (USD Million)
10.2.7. Russia and CIS X-Ray Contrast Agents Market Overview, 2017 - 2028 (USD Million)
10.2.7.1. Russia and CIS X-Ray Contrast Agents Market Overview, By Media/Agent Type, 2017 - 2028 (USD Million)
10.2.7.2. Russia and CIS X-Ray Contrast Agents Market Overview, By Mode of Administration, 2017 - 2028 (USD Million)
10.2.7.3. Russia and CIS X-Ray Contrast Agents Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.7.4. Russia and CIS X-Ray Contrast Agents Market Overview, By End User, 2017 - 2028 (USD Million)
10.2.8. Rest of Europe X-Ray Contrast Agents Market Overview, 2017 - 2028 (USD Million)
10.2.8.1. Rest of Europe X-Ray Contrast Agents Market Overview, By Media/Agent Type, 2017 - 2028 (USD Million)
10.2.8.2. Rest of Europe X-Ray Contrast Agents Market Overview, By Mode of Administration, 2017 - 2028 (USD Million)
10.2.8.3. Rest of Europe X-Ray Contrast Agents Market Overview, By Indication, 2017 - 2028 (USD Million)
10.2.8.4. Rest of Europe X-Ray Contrast Agents Market Overview, By End User, 2017 - 2028 (USD Million)
 
Chapter 11. Asia Pacific X-Ray Contrast Agents Market Overview, By Countries, 2017 - 2028 (USD Million)
11.1. Asia Pacific X-Ray Contrast Agents Market Overview, 2017 - 2028 (USD Million)
11.1.1. Market size and projections, 2017 - 2028 (USD Million)
11.1.2. Asia Pacific X-Ray Contrast Agents Market Overview, By Media/Agent Type, 2017 - 2028 (USD Million)
11.1.3. Asia Pacific X-Ray Contrast Agents Market Overview, By Mode of Administration, 2017 - 2028 (USD Million)
11.1.4. Asia Pacific X-Ray Contrast Agents Market Overview, By Indication, 2017 - 2028 (USD Million)
11.1.5. Asia Pacific X-Ray Contrast Agents Market Overview, By End User, 2017 - 2028 (USD Million)
11.2. Asia Pacific X-Ray Contrast Agents Market Overview, By Countries, 2017 - 2028 (USD Million)
11.2.1. India X-Ray Contrast Agents Market Overview, 2017 - 2028 (USD Million)
11.2.1.1. India X-Ray Contrast Agents Market Overview, By Media/Agent Type, 2017 - 2028 (USD Million)
11.2.1.2. India X-Ray Contrast Agents Market Overview, By Mode of Administration, 2017 - 2028 (USD Million)
11.2.1.3. India X-Ray Contrast Agents Market Overview, By Indication, 2017 - 2028 (USD Million)
11.2.1.4. India X-Ray Contrast Agents Market Overview, By End User, 2017 - 2028 (USD Million)
11.2.2. China X-Ray Contrast Agents Market Overview, 2017 - 2028 (USD Million)
11.2.2.1. China X-Ray Contrast Agents Market Overview, By Media/Agent Type, 2017 - 2028 (USD Million)
11.2.2.2. China X-Ray Contrast Agents Market Overview, By Mode of Administration, 2017 - 2028 (USD Million)
11.2.2.3. China X-Ray Contrast Agents Market Overview, By Indication, 2017 - 2028 (USD Million)
11.2.2.4. China X-Ray Contrast Agents Market Overview, By End User, 2017 - 2028 (USD Million)
11.2.3. Japan X-Ray Contrast Agents Market Overview, 2017 - 2028 (USD Million)
11.2.3.1. Japan X-Ray Contrast Agents Market Overview, By Media/Agent Type, 2017 - 2028 (USD Million)
11.2.3.2. Japan X-Ray Contrast Agents Market Overview, By Mode of Administration, 2017 - 2028 (USD Million)
11.2.3.3. Japan X-Ray Contrast Agents Market Overview, By Indication, 2017 - 2028 (USD Million)
11.2.3.4. Japan X-Ray Contrast Agents Market Overview, By End User, 2017 - 2028 (USD Million)
11.2.4. ASEAN X-Ray Contrast Agents Market Overview, 2017 - 2028 (USD Million)
11.2.4.1. ASEAN X-Ray Contrast Agents Market Overview, By Media/Agent Type, 2017 - 2028 (USD Million)
11.2.4.2. ASEAN X-Ray Contrast Agents Market Overview, By Mode of Administration, 2017 - 2028 (USD Million)
11.2.4.3. ASEAN X-Ray Contrast Agents Market Overview, By Indication, 2017 - 2028 (USD Million)
11.2.4.4. ASEAN X-Ray Contrast Agents Market Overview, By End User, 2017 - 2028 (USD Million)
11.2.5. South Korea X-Ray Contrast Agents Market Overview, 2017 - 2028 (USD Million)
11.2.5.1. South Korea X-Ray Contrast Agents Market Overview, By Media/Agent Type, 2017 - 2028 (USD Million)
11.2.5.2. South Korea X-Ray Contrast Agents Market Overview, By Mode of Administration, 2017 - 2028 (USD Million)
11.2.5.3. South Korea X-Ray Contrast Agents Market Overview, By Indication, 2017 - 2028 (USD Million)
11.2.5.4. South Korea X-Ray Contrast Agents Market Overview, By End User, 2017 - 2028 (USD Million)
11.2.6. Australia X-Ray Contrast Agents Market Overview, 2017 - 2028 (USD Million)
11.2.6.1. Australia X-Ray Contrast Agents Market Overview, By Media/Agent Type, 2017 - 2028 (USD Million)
11.2.6.2. Australia X-Ray Contrast Agents Market Overview, By Mode of Administration, 2017 - 2028 (USD Million)
11.2.6.3. Australia X-Ray Contrast Agents Market Overview, By Indication, 2017 - 2028 (USD Million)
11.2.6.4. Australia X-Ray Contrast Agents Market Overview, By End User, 2017 - 2028 (USD Million)
11.2.7. Rest of Asia Pacific X-Ray Contrast Agents Market Overview, 2017 - 2028 (USD Million)
11.2.7.1. Rest of Asia Pacific X-Ray Contrast Agents Market Overview, By Media/Agent Type, 2017 - 2028 (USD Million)
11.2.7.2. Rest of Asia Pacific X-Ray Contrast Agents Market Overview, By Mode of Administration, 2017 - 2028 (USD Million)
11.2.7.3. Rest of Asia Pacific X-Ray Contrast Agents Market Overview, By Indication, 2017 - 2028 (USD Million)
11.2.7.4. Rest of Asia Pacific X-Ray Contrast Agents Market Overview, By End User, 2017 - 2028 (USD Million)
 
Chapter 12. South America X-Ray Contrast Agents Market Overview, By Countries, 2017 - 2028 (USD Million)
12.1. South America X-Ray Contrast Agents Market Overview, 2017 - 2028 (USD Million)
12.1.1. Market size and projections, 2017 - 2028 (USD Million)
12.1.2. South America X-Ray Contrast Agents Market Overview, By Media/Agent Type, 2017 - 2028 (USD Million)
12.1.3. South America X-Ray Contrast Agents Market Overview, By Mode of Administration, 2017 - 2028 (USD Million)
12.1.4. South America X-Ray Contrast Agents Market Overview, By Indication, 2017 - 2028 (USD Million)
12.1.5. South America X-Ray Contrast Agents Market Overview, By End User, 2017 - 2028 (USD Million)
12.2. South America X-Ray Contrast Agents Market Overview, By Countries, 2017 - 2028 (USD Million)
12.2.1. Brazil X-Ray Contrast Agents Market Overview, 2017 - 2028 (USD Million)
12.2.1.1. Brazil X-Ray Contrast Agents Market Overview, By Media/Agent Type, 2017 - 2028 (USD Million)
12.2.1.2. Brazil X-Ray Contrast Agents Market Overview, By Mode of Administration, 2017 - 2028 (USD Million)
12.2.1.3. Brazil X-Ray Contrast Agents Market Overview, By Indication, 2017 - 2028 (USD Million)
12.2.1.4. Brazil X-Ray Contrast Agents Market Overview, By End User, 2017 - 2028 (USD Million)
12.2.2. Argentina X-Ray Contrast Agents Market Overview, 2017 - 2028 (USD Million)
12.2.2.1. Argentina X-Ray Contrast Agents Market Overview, By Media/Agent Type, 2017 - 2028 (USD Million)
12.2.2.2. Argentina X-Ray Contrast Agents Market Overview, By Mode of Administration, 2017 - 2028 (USD Million)
12.2.2.3. Argentina X-Ray Contrast Agents Market Overview, By Indication, 2017 - 2028 (USD Million)
12.2.2.4. Argentina X-Ray Contrast Agents Market Overview, By End User, 2017 - 2028 (USD Million)
12.2.3. Rest of South America X-Ray Contrast Agents Market Overview, 2017 - 2028 (USD Million)
12.2.3.1. Rest of South America X-Ray Contrast Agents Market Overview, By Media/Agent Type, 2017 - 2028 (USD Million)
12.2.3.2. Rest of South America X-Ray Contrast Agents Market Overview, By Mode of Administration, 2017 - 2028 (USD Million)
12.2.3.3. Rest of South America X-Ray Contrast Agents Market Overview, By Indication, 2017 - 2028 (USD Million)
12.2.3.4. Rest of South America X-Ray Contrast Agents Market Overview, By End User, 2017 - 2028 (USD Million)
 
Chapter 13. Middle East & Africa X-Ray Contrast Agents Market Overview, By Countries, 2017 - 2028 (USD Million)
13.1. Middle East & Africa X-Ray Contrast Agents Market Overview, 2017 - 2028 (USD Million)
13.1.1. Market size and projections, 2017 - 2028 (USD Million)
13.1.2. Middle East & Africa X-Ray Contrast Agents Market Overview, By Media/Agent Type, 2017 - 2028 (USD Million)
13.1.3. Middle East & Africa X-Ray Contrast Agents Market Overview, By Mode of Administration, 2017 - 2028 (USD Million)
13.1.4. Middle East & Africa X-Ray Contrast Agents Market Overview, By Indication, 2017 - 2028 (USD Million)
13.1.5. Middle East & Africa X-Ray Contrast Agents Market Overview, By End User, 2017 - 2028 (USD Million)
13.2. Middle East & Africa X-Ray Contrast Agents Market Overview, By Countries, 2017 - 2028 (USD Million)
13.2.1. GCC X-Ray Contrast Agents Market Overview, 2017 - 2028 (USD Million)
13.2.1.1. GCC X-Ray Contrast Agents Market Overview, By Media/Agent Type, 2017 - 2028 (USD Million)
13.2.1.2. GCC X-Ray Contrast Agents Market Overview, By Mode of Administration, 2017 - 2028 (USD Million)
13.2.1.3. GCC X-Ray Contrast Agents Market Overview, By Indication, 2017 - 2028 (USD Million)
13.2.1.4. GCC X-Ray Contrast Agents Market Overview, By End User, 2017 - 2028 (USD Million)
13.2.2. South Africa X-Ray Contrast Agents Market Overview, 2017 - 2028 (USD Million)
13.2.2.1. South Africa X-Ray Contrast Agents Market Overview, By Media/Agent Type, 2017 - 2028 (USD Million)
13.2.2.2. South Africa X-Ray Contrast Agents Market Overview, By Mode of Administration, 2017 - 2028 (USD Million)
13.2.2.3. South Africa X-Ray Contrast Agents Market Overview, By Indication, 2017 - 2028 (USD Million)
13.2.2.4. South Africa X-Ray Contrast Agents Market Overview, By End User, 2017 - 2028 (USD Million)
13.2.3. Rest of Middle East & Africa X-Ray Contrast Agents Market Overview, 2017 - 2028 (USD Million)
13.2.3.1. Rest of Middle East & Africa X-Ray Contrast Agents Market Overview, By Media/Agent Type, 2017 - 2028 (USD Million)
13.2.3.2. Rest of Middle East & Africa X-Ray Contrast Agents Market Overview, By Mode of Administration, 2017 - 2028 (USD Million)
13.2.3.3. Rest of Middle East & Africa X-Ray Contrast Agents Market Overview, By Indication, 2017 - 2028 (USD Million)
13.2.3.4. Rest of Middle East & Africa X-Ray Contrast Agents Market Overview, By End User, 2017 - 2028 (USD Million)
 
Chapter 14. Competitive Landscape
14.1. Competitive Environment, 2021
14.2. Strategic Framework
14.2.1. Partnership/Collaborations/Agreement
14.2.2. Expansion
14.2.3. Mergers & Acquisitions
14.2.4. New Product Development
 
Chapter 15. Key Vendor Analysis
15.1. GE Healthcare
15.1.1. Business Overview
15.1.2. Product Benchmarking
15.1.3. Financial Data
15.1.4. Strategic Overview
15.1.5. Key Developments
15.1.6. SWOT Analysis
15.2. Bracco Imaging SPA
15.2.1. Business Overview
15.2.2. Product Benchmarking
15.2.3. Financial Data
15.2.4. Strategic Overview
15.2.5. Key Developments
15.2.6. SWOT Analysis
15.3. Bayer AG
15.3.1. Business Overview
15.3.2. Product Benchmarking
15.3.3. Financial Data
15.3.4. Strategic Overview
15.3.5. Key Developments
15.3.6. SWOT Analysis
15.4. Guerbet
15.4.1. Business Overview
15.4.2. Product Benchmarking
15.4.3. Financial Data
15.4.4. Strategic Overview
15.4.5. Key Developments
15.4.6. SWOT Analysis
15.5. Lantheus Medical Imaging, Inc.
15.5.1. Business Overview
15.5.2. Product Benchmarking
15.5.3. Financial Data
15.5.4. Strategic Overview
15.5.5. Key Developments
15.5.6. SWOT Analysis
15.6. Unijules Life Sciences
15.6.1. Business Overview
15.6.2. Product Benchmarking
15.6.3. Financial Data
15.6.4. Strategic Overview
15.6.5. Key Developments
15.6.6. SWOT Analysis
15.7. JB Pharma
15.7.1. Business Overview
15.7.2. Product Benchmarking
15.7.3. Financial Data
15.7.4. Strategic Overview
15.7.5. Key Developments
15.7.6. SWOT Analysis
15.8. SANOCHEMIA Pharmazeutika GmbH
15.8.1. Business Overview
15.8.2. Product Benchmarking
15.8.3. Financial Data
15.8.4. Strategic Overview
15.8.5. Key Developments
15.8.6. SWOT Analysis
15.9. Jodas Expoim
15.9.1. Business Overview
15.9.2. Product Benchmarking
15.9.3. Financial Data
15.9.4. Strategic Overview
15.9.5. Key Developments
15.9.6. SWOT Analysis
15.10. Nano Therapeutics Pvt. Ltd.
15.10.1. Business Overview
15.10.2. Product Benchmarking
15.10.3. Financial Data
15.10.4. Strategic Overview
15.10.5. Key Developments
15.10.6. SWOT Analysis

15.11. Kiran X-ray
15.11.1. Business Overview
15.11.2. Product Benchmarking
15.11.3. Financial Data
15.11.4. Strategic Overview
15.11.5. Key Developments
15.11.6. SWOT Analysis
15.12. iMax Diagnostic Imaging Limited
15.12.1. Business Overview
15.12.2. Product Benchmarking
15.12.3. Financial Data
15.12.4. Strategic Overview
15.12.5. Key Developments
15.12.6. SWOT Analysis
15.13. Livealth Biopharma Pvt. Ltd.
15.13.1. Business Overview
15.13.2. Product Benchmarking
15.13.3. Financial Data
15.13.4. Strategic Overview
15.13.5. Key Developments
15.13.6. SWOT Analysis
15.14. Trivitron Healthcare Pvt. Ltd.
15.14.1. Business Overview
15.14.2. Product Benchmarking
15.14.3. Financial Data
15.14.4. Strategic Overview
15.14.5. Key Developments
15.14.6. SWOT Analysis
 
Chapter 16. Future Outlook of the Market